Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer

被引：0
|
作者：
Kathleen Moore
John K. Chan
Angeles Alvarez Secord
Manish R. Patel
Timothy Callahan
Wei Guo
Zhi-Yi Zhang
机构：
[1] University of Oklahoma HSC,Stephenson Cancer Center
[2] Sarah Cannon Research Institute,Palo Alto Medical Foundation, California Pacific Medical Center
[3] Sutter Health Sutter West Bay,undefined
[4] Duke Cancer Institute,undefined
[5] Florida Cancer Specialists and Research Institute,undefined
[6] BioTel Research,undefined
[7] TESARO,undefined
[8] Inc,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Niraparib; PARP inhibitor; Cardiac repolarization; QTc interval; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 726
页数：9
相关论文
共 50 条
  • [31] A phase 2 study to assess olaparib by homologous recombination deficiency status in patients with platinum-sensitive, relapsed, ovarian, fallopian tube, or primary peritoneal cancer.
    Cadoo, Karen Anne
    Aghajanian, Carol
    Fraser, Cindy
    Milner, Alvin
    Kolvenbag, Geert
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer
    Kongsawatvorakul, Chompunoot
    Charakorn, Chuenkamon
    Chittithaworn, Suwicha
    Lertkhachonsuk, Arb-Aroon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (06) : 2331 - 2335
  • [33] Real-life data of niraparib maintenance treatment in patients with recurrent platinum-sensitive ovarian cancer.
    Vilming, Bente
    Fallas-Dahl, Jorgen
    Bentzen, Anne-Gry
    Ingebrigtsen, Vibeke Anett
    Nilsen, Elisabeth Berge
    Vistad, Ingvild
    Dorum, Anne
    Solheim, Olesya
    Bjorge, Line
    Aune, Guro
    Lindemann, Kristina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Management of platinum-sensitive recurrent ovarian cancer
    Pfisterer, Jacobus
    Ledermann, Jonathan A.
    SEMINARS IN ONCOLOGY, 2006, 33 (02) : S12 - S16
  • [35] Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
    Pecorelli, S.
    Ray-Coquard, I.
    Tredan, O.
    Colombo, N.
    Parma, G.
    Tisi, G.
    Katsaros, D.
    Lhomme, C.
    Lissoni, A. A.
    Vermorken, J. B.
    du Bois, A.
    Poveda, A.
    Frigerio, L.
    Barbieri, P.
    Carminati, P.
    Brienza, S.
    Guastalla, J. P.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 759 - 765
  • [36] BUDGET IMPACT OF NIRAPARIB AS MAINTENANCE TREATMENT FOR MEDICARE PATIENTS WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER WHO ARE IN COMPLETE OR PARTIAL RESPONSE TO PLATINUM-BASED CHEMOTHERAPY
    Neeser, K.
    O'Neil, W. M.
    Stern, L.
    VALUE IN HEALTH, 2018, 21 : S21 - S21
  • [37] SAFETY AND EFFICACY OF NIRAPARIB IN PATIENTS WITH ADVANCED, RELAPSED, HIGH-GRADE SEROUS EPITHELIAL OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER (QUADRA)
    Moore, K.
    Rimel, B. J.
    Achour, H.
    Naumov, G.
    Agarwal, S.
    Balser, J.
    Monk, B. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 784 - 784
  • [38] A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer
    Case, Ashley S.
    Rocconi, Rodney P.
    Partridge, Edward E.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 223 - 227
  • [39] Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer
    Kim, Se Ik
    Lee, Eun Ji
    Lee, Maria
    Chung, Hyunhoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Kim, Hee Seung
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (12) : 1943 - 1950
  • [40] Secondary Cytoreductive Surgery in the Management of Platinum-Sensitive Recurrent Epithelial Ovarian Cancer
    Park, Jeong-Yeol
    Eom, Jeong-Min
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (05) : 418 - 424
12345